Apoptone (HE3235), patented by Harbor BioSciences in 2010, is a novel synthetic steroid analog of a dihydrotestosterone metabolite. It has been found to stimulate cell death (apoptosis) in animal models of prostate and breast cancers, and is currently in Phase I/II clinical trials for patients with advanced prostate cancer. On September 14, 2010, ...
Found on http://en.wikipedia.org/wiki/Apoptone
No exact match found